title: Present and future approaches to screening of G-protein-coupled receptors.
abstract: As G-protein-coupled receptors (GPCRs) mediate a multitude of cellular signal transduction events, affecting more or less all human disease areas, it is, therefore, no surprise that they comprise the largest family of current drug targets. Screening of compounds interacting with GPCRs has developed during the past decade from receptor binding assays, to various functional determination of coupling to G-proteins, and, more recently, G-protein-independent signal transduction events. Additional opportunities have been presented in drug discovery through novel pharmacological properties obtained for receptor dimers and by identification of ligands for orphan GPCRs. Furthermore, high-throughput formats and automation has substantially facilitated and accelerated the screening process providing powerful tools in improving modern drug discovery.
authors.affiliation: PanTherapeutics, Rue des Remparts 4, CH1095 Lutry, Switzerland. lundstromkenneth@gmail.com
authors.forename: Kenneth
authors.initials: K
authors.lastname: Lundstrom
mesh_terms: D000818:Animals; D019390:Arrestins / Q000378:metabolism; D002118:Calcium / Q000378:metabolism; D000242:Cyclic AMP / Q000378:metabolism; D055808:Drug Discovery / Q000379:methods*; D017930:Genes, Reporter; D016244:Guanosine 5'-O-(3-Thiotriphosphate) / Q000378:metabolism; D006801:Humans; D007295:Inositol Phosphates / Q000378:metabolism; D043562:Receptors, G-Protein-Coupled / Q000032:analysis* / Q000378:metabolism*; D015398:Signal Transduction; D000071557:beta-Arrestins
chemical_list: D019390:Arrestins; D007295:Inositol Phosphates; D043562:Receptors, G-Protein-Coupled; D000071557:beta-Arrestins; D016244:Guanosine 5'-O-(3-Thiotriphosphate); D000242:Cyclic AMP; D002118:Calcium